Related Experiment Video
Updated: Sep 26, 2025

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
Published on: December 23, 2020
SARS-CoV-2 hijacks host cell genome instability pathways
Joshua Victor1, Tristan Jordan2, Erica Lamkin1
1University of Vermont.
Abstract:
The repertoire of coronavirus disease 2019 (COVID-19)-mediated adverse health outcomes has continued to expand in infected patients, including the susceptibility to developing long-COVID; however, the molecular underpinnings at the cellular level are poorly defined. In this study, we report that SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection triggers host cell genome instability by modulating the expression of molecules of DNA repair and mutagenic translesion synthesis. Further, SARS-CoV-2 infection causes genetic alterations, such as increased mutagenesis, telomere dysregulation, and elevated microsatellite instability (MSI). The MSI phenotype was coupled to reduced MLH1, MSH6, and MSH2 in infected cells. Strikingly, pre-treatment of cells with the REV1-targeting translesion DNA synthesis inhibitor, JH-RE-06, suppresses SARS-CoV-2 proliferation and dramatically represses the SARS-CoV-2-dependent genome instability. Mechanistically, JH-RE-06 treatment induces autophagy, which we hypothesize limits SARS-CoV-2 proliferation and, therefore, the hijacking of host-cell genome instability pathways. These results have implications for understanding the pathobiological consequences of COVID-19.
Insights
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes genome instability and genetic alterations in host cells. A novel inhibitor, JH-RE-06, suppresses viral proliferation and DNA damage, offering therapeutic potential.
Area of Science:
- Molecular Biology
- Genetics
- Virology
Background:
- The molecular mechanisms underlying COVID-19's adverse health outcomes, including long-COVID, remain unclear.
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection's impact on host cell genome integrity is poorly understood.
Approach:
- Investigated SARS-CoV-2's effect on host cell DNA repair and translesion synthesis pathways.
- Analyzed genetic alterations such as mutagenesis, telomere dysregulation, and microsatellite instability (MSI) in infected cells.
- Examined the impact of a REV1 inhibitor (JH-RE-06) on viral proliferation and genome instability.
Key Points:
- SARS-CoV-2 infection induces host cell genome instability by altering DNA repair and translesion synthesis.
- Infection leads to increased mutagenesis, telomere dysregulation, and MSI, linked to reduced DNA repair proteins (MLH1, MSH6, MSH2).
- JH-RE-06, a translesion DNA synthesis inhibitor, suppressed SARS-CoV-2 proliferation and genome instability, potentially via autophagy induction.
Conclusions:
- SARS-CoV-2 infection compromises host cell genome stability, contributing to COVID-19's pathology.
- Targeting translesion DNA synthesis with inhibitors like JH-RE-06 may offer a therapeutic strategy against SARS-CoV-2 and its associated genomic consequences.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers
Retroviruses
Viral Recombination
Viruses with RNA Genomes
DNA Damage can Stall the Cell Cycle

